Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daily Delight
- Development stage
- Unknown
- Lead developer
- Medterra
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Daily Delight is a consumer wellness product developed by Medterra in the form of oral gummies. Each gummy contains 25mg of CBD (cannabidiol) and 5mg of THC as active ingredients, derived from full-spectrum hemp extract (33mg total per gummy). The product is marketed as a daily wellness supplement designed to help users manage stress, promote relaxation, and enhance mood. The cannabinoids interact with the body's endocannabinoid system to provide a calming effect. The gummies are formulated with natural ingredients including organic tapioca syrup, pectin, and fruit juices. The product is hemp-derived and federally legal under the 2018 Farm Bill, containing less than 0.3% THC by weight. Medterra positions this product as part of their high-potency wellness collection for general well-being rather than as a pharmaceutical drug for treating specific medical conditions.
- Brand names
- Daily Delight
- Other names
- Medterra Daily Delight CBD Gummy
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Daily Delight.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daily Delight.